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Abstract 
Calciphylaxis is a deadly disease seen primarily in patients with end stage renal disease. 
Literature indicated that improved patient outcomes are seen with routine screenings. 
Many dialysis providers lack fundamental knowledge that would enable early 
identification of calciphylaxis in patients with renal disease. The purpose of this project 
was to design a screening instrument and develop a staff education program that would 
transform calciphylaxis management by promoting early identification and treatment of 
the disease. Knowles’s theory of andragogy was used as the theoretic framework for the 
project. Dialysis center staff (n = 26) participated in the education. The number of 
participants was based on the number of staff working at the partner dialysis site. There 
were no exclusions as all members of the interdisciplinary team play an important role in 
calciphylaxis management. Surveys conducted following the education were used to 
determine whether dialysis staff believed they had acquired the knowledge and skills 
necessary to identify early signs of calciphylaxis.  Descriptive data collected by the 
surveys indicated 60% of participants were not at all comfortable identifying patients at 
risk for developing calciphylaxis prior to attending the education presentation. Following 
the presentation, 68% of participants felt very comfortable identifying at-risk patients, an 
increase of 82.3%. This project exemplified that calciphylaxis detection is a secondary 
prevention nursing intervention that has potential for promoting positive social change by 
improving patient outcomes, reducing mortality rates in the end stage renal disease 
population, and providing empirical data to inform evidence-based therapies for at-risk 
patients. 
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Section 1: Nature of the Project 
Introduction 
End-stage renal disease (ESRD) occurs when the kidneys can no longer clear the 
body of uremic toxins. ESRD is the most severe stage of chronic kidney disease and 
requires renal replacement therapy to sustain life (National Kidney Foundation, 2002). 
The U.S. Renal Data System (USRDS) reported 703,243 prevalent ESRD cases in the 
United States at year end in 2015 (Saran et al., 2017). This represents 0.21% of the U.S. 
population, an increase of 2.4% from the previous year and a 58% increase from the year 
2000 (Saran et al., 2017). Likewise, the incidence of ESRD has also been on the rise. As 
reported by the USRDS, there were 112,114 newly diagnosed ESRD cases in 2015 
(Saran et al., 2017). Chronic kidney disease and ESRD not only affect population health 
but can also represent a health-related quality of life (HRQOL) burden for the individual. 
Frequent hospitalizations and increased mortality risks have been associated with poor 
HRQOL (Chen, Mawed, & Unruh, 2016). Multiple comorbid conditions such as anemia, 
disordered bone metabolism, cardiovascular disease, and infections are all factors that 
negatively impact a person’s HRQOL. As the incident and prevalent rates of ESRD have 
continued to rise, there has been an increased demand upon health care resources to 
manage the life-sustaining needs of the ESRD population as well as treating the many 
associated comorbidities (Saran et al., 2017).  
Calciphylaxis is a serious disease seen predominately in the ESRD population. 
The disease process has been described as calcifying panniculitis, necrotizing 
panniculitis, calcific uremic arteriolopathy (CUA), nonuremic calcific arteriolopathy, and 
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calcinosis cutis. Hans Seyle first described calciphylaxis in 1962 as an anaphylactic 
reaction to calcium (Nigwekar et al., 2015). While this description does not accurately 
describe the pathology of calciphylaxis, the term is universally known. For this reason, 
the term calciphylaxis will be used throughout this paper.  
Brandenburg et al. (2016) described calciphylaxis as a “challenging disease with a 
dismal prognosis urgently requiring adequate strategies for diagnosis and treatment” (p. 
1211). Calciphylaxis is a form of extraskeletal calcification characterized by the 
deposition of calcium salts in the subcutaneous tissues (Zacharias, Fontaine, & Fine, 
1999) and thrombosis of the small arterioles of the skin (Moorthi & Moe, 2011). In 
advanced stages, calciphylaxis can lead to tissue ischemia, necrosis, and pain (Jeong & 
Dominguez, 2016). Calciphylaxis has been reported to affect from 1% to 4% of the 
ESRD population (Brandenburg et al., 2016). According to Nigwekar et al. (2014), actual 
epidemiological counts are difficult to quantify because there is no unique International 
Classification of Diseases (ICD) code specific for calciphylaxis. Under ICD-10, 
calciphylaxis is coded as E83.59 – other disorders of calcium metabolism. This 
nonspecific classification has led to a lack of precise epidemiological data, making it 
difficult to fully appreciate the prevalence of calciphylaxis or to track disease trends 
accurately. Additionally, as Nigwekar et al. argued,  
lack of data on fundamental issues such as incidence, prevalence, or mortality for 
any condition seriously impairs future patient-oriented translational research and 
limits investigators’ abilities to examine temporal trends, epidemiological 
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associations, and development of diagnostic biomarkers and novel therapy targets. 
(pp. S924-S925)  
For this reason, there seems to have been a void in evidence-based research to guide the 
treatment of calciphylaxis. One prevalent theme in the literature indicated that routine 
screening, early identification, and early intervention of calciphylaxis could improve 
patient outcomes. Despite this, research regarding any screening process has been 
lacking. There is a practice gap with regards to conducting routine screenings and, as 
Brandenburg et al. noted, many providers lack the knowledge and skills necessary to 
identify early signs of calciphylaxis. For this DNP project, I have looked to fill the 
practice and knowledge gaps by developing a calciphylaxis screening tool to use in 
clinical practice and developing a staff education project to provide dialysis staff with the 
knowledge and skills necessary to identify calciphylaxis in the ESRD population. 
Positive social implications could be realized through early detection and treatment of 
calciphylaxis, thereby reducing the physical burden of advanced disease and reducing 
health care spending.  
Problem Statement 
As reported by the USRDS, the nephrology community has seen an alarming 
increase in the incident and prevalent dialysis population in the 35-year period from 1980 
through 2015. Trends in incident and prevalent ESRD populations are documented 
annually by the USRDS. In 1980, there was a reported incident ESRD count of 17,902 
with an adjusted rate (million/year) of 87 and a reported prevalence count of 56,434 with 
an age-sex-race standardization per million of 273.7 (Saran et al., 2017). Compare this to 
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current trends in 2015. In 2015, there was a reported incident ESRD count of 124,114 
with and adjusted rate (million/year) of 357 and a reported prevalence count of 703,243 
with an age-sex-race standardization per million years of 2,023.6 (Saran et al., 2017). 
This rapid growth in the ESRD population coupled with increased awareness of the 
disease process is likely responsible for an increasing number of patients now being 
diagnosed with calciphylaxis.  
Late stages of calciphylaxis are characterized by vascular calcification, tissue 
necrosis, and the ensuing development of painful skin ulcers (Magro, Simman, & 
Jackson, 2010). While calciphylaxis pathogenesis remains a mystery (Bliss, 2002), 
researchers do know that the ulcerative lesions are associated with considerable pain, 
suffering, and a mortality rate 2.5 to 3 times higher than in ESRD patients without 
calciphylaxis (Nigwekar et al., 2014). Although there are no data on the number of 
patients who are misdiagnosed or whose diagnosis is delayed, the importance of early 
diagnosis and treatment is well documented. The lack of evidence regarding routine 
calciphylaxis assessment and screening has clearly indicated that there is gap in clinical 
practice that calls for action. Parker, Mouton, Young, and Espino (2003) reported a 
calciphylaxis associated mortality rate of 86%, while Wangen, Anderson, Fencl, and 
Mangan (2014) reported a median survival of 2.6 months following diagnosis. 
Calciphylaxis lesions are often seen as soft tissue calcifications or ulcerative wounds of 
the skin. The underlying pathology of calciphylaxis is related to endoluminal calcification 
of the vasculature and, as such, calciphylaxis can affect any other organ system. 
Calciphylaxis has been noted to affect the heart and gastrointestinal tract (Magro et al., 
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2010). Not all calciphylaxis is ulcerative or systemic. As Fine and Zacharias (2002) 
noted, calciphylaxis can be nonulcerating and often goes undiagnosed. Herein lies the 
need for routine calciphylaxis screening in the ESRD population. With the current trends 
in ESRD epidemiology, routine screening for calciphylaxis becomes crucial.  
Patients with chronic kidney disease carry a higher burden for cardiovascular 
disease than the general population (Saran et al., 2017). According to the USRDS, 
cardiovascular death is the largest category of known cause mortality in the ESRD 
population (Saran et al., 2017). In 2015, cardiovascular deaths were broken down into the 
following categories: 40% arrhythmia and cardiac arrest, 6% acute myocardial infarction 
and arteriosclerotic heart disease, 3% congestive heart failure, 3% cerebral vascular 
accident, and 3% other cardiac causes (Saran et al., 2017). Systemic calciphylaxis has 
been implicated as contributing to the high rate of cardiovascular death among patients 
with chronic kidney disease due to cardiac artery calcifications (Lee, Belozeroff, Song, 
Diakun, & Goodman, 2013). Evidence-based treatment of calciphylaxis has remained 
elusive. Literature supported improved outcomes if calciphylaxis was identified and 
treated prior to the onset of ulcerative lesions (Feeser, 2011; Sprague, 2014). A practice 
void has persisted because the literature is devoid of evidence or even expert opinions 
that would inform a process for conducting routine calciphylaxis screening. 
 As a nurse practitioner practicing in the outpatient hemodialysis unit, I have 
personal experience to indicate that the incidence of calciphylaxis with ulcerative lesions 
is becoming more prevalent than in previous years. This is no doubt a reflection of a 
growing ESRD population and increased clinical awareness. Fine and Zacharias (2002) 
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found a high prevalence of nonulcerating calciphylaxis in their dialysis population and 
concluded that the incidence of calciphylaxis is much higher than described in the 
literature. If this is true, then health care teams are doing a disservice to the ESRD 
population and need to become more proactive in early screening and disease detection. 
Whether due to underdiagnosis or a growing ESRD population, calciphylaxis 
presents a population health challenge. There is a knowledge gap in hemodialysis clinical 
practice as well as the absence of any screening tool to inform clinical assessment. Filling 
this gap may assist nurses and advanced practitioners to recognize the early signs of 
calciphylaxis that, if left unchecked, could potentially lead to advanced disease. This 
presupposes a need for educational training to provide dialysis nurses with the 
foundations and skills necessary to recognize impending serious sequela. Despins, Scott-
Cawiezell, and Rouder (2010) recognized that quality care could be improved if nurses 
had the tools available to help them identify risk factors or early signs of impending 
injury. 
This DNP project has the potential to transform calciphylaxis management by 
nephrology nurses. With development of a calciphylaxis screening tool and education of 
nurses on how to use the tool in clinical practice, this DNP project could lead to the 
transformation of nephrology nurses into clinical nurse leaders in calciphylaxis 
management.  
Purpose 
A gap analysis of calciphylaxis management revealed a knowledge gap, as many 
nephrology nurse providers do not know how to identify physical signs of calciphylaxis. 
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There also exists a practice gap in that routine calciphylaxis screenings are not being 
conducted. 
The purpose of this DNP project is twofold: first, to design a calciphylaxis 
screening tool that could be used in clinical practice and second, to develop a continuing 
nurse education activity that would provide dialysis staff with the education and skills 
necessary to conduct a clinical screening for the purpose of identifying calciphylaxis in 
the clinical setting. 
This DNP project addressed two practice focused questions:  
1. What are the best practices based on literature evidence and expert opinion to 
be incorporated in a calciphylaxis assessment and screening tool? 
2. Will dialysis staff who participate in a staff education activity, regarding 
calciphylaxis assessment and screening, acquire the knowledge and skills 
necessary to effectively identify calciphylaxis in the clinical setting? 
It is clear from the research that there is a lack of evidence or opinions regarding 
best practices in the management of calciphylaxis. Brandenburg et al. (2016) 
acknowledged unmet medical needs in calciphylaxis management that are due to the 
scarcity of evidence. Brandenburg et al. identified an urgent need for clinical guidance in 
this area of medicine. With this DNP project, I addressed the practice void by developing 
an assessment tool that, once validated, could be used to guide the process of routine 
calciphylaxis screening. 
A successful calciphylaxis screening program is dependent on nurses who possess 
a fundamental knowledge of calciphylaxis and can apply this knowledge in clinical 
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practice. This DNP project addressed the knowledge gap with the development of a staff 
education activity that provided dialysis staff with the fundamental knowledge and the 
core competencies to conduct a calciphylaxis screening and identify calciphylaxis lesions 
in clinical practice. 
The Nature of the Doctoral Project 
A literature search failed to produce any nursing protocol related to screening, 
identification, or treatment of calciphylaxis in the ESRD population. There have been 
numerous case studies, some anecdotal evidence, and expert opinion, but there was a 
dearth of solid evidence. The literature search was replete with references to the lack of 
evidence or best practices. What I derived from the evidence was that early identification, 
diagnosis, and intervention is paramount to improving outcomes and minimizing 
complications  (Feeser, 2011; Fine & Zacharias, 2002; Sprague, 2013). 
There were two components to the DNP project. The first was to design a 
calciphylaxis screening tool that could be easily integrated into clinical practice without 
being unduly burdensome or disrupting unit workflow. The assessment and screening 
tool was designed to incorporate the current monthly diabetic foot exam and pain 
assessment. Development of the assessment and screening tool was based on current 
evidence and expert opinion regarding calciphylaxis pathophysiology; best practices in 
skin and wound assessment, screening, and surveillance; and a multidimensional pain 
assessment. Once developed, the assessment and screening tool was offered to 
participants during the continuing education activity for evaluation and to solicit 
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recommendations for improvement. The tool was not validated as part of the DNP project 
but is expected take place outside of the DNP project. 
The second element of the DNP project involved working with a partner dialysis 
organization to provide dialysis staff with the knowledge and skills necessary to conduct 
a routine calciphylaxis screening. The staff education activity offered attendees 1.5 hours 
of continuing education credits. The objectives of the presentation were to educate 
participants (a) to understand the pathophysiology of calciphylaxis, (b) to identify 
patients at risk of developing calciphylaxis, and (c) to provide the skills needed to 
identify calciphylaxis lesions in the clinical setting. This staff education project was 
designed to incorporate an interdisciplinary approach for achieving early intervention by 
empowering frontline nurses to assume a proactive leadership role, apply critical 
assessment skills, assess risk factors, and identify potential signs of calciphylaxis in the 
dialysis patient population. 
I used several evaluation techniques for data analysis. A retrospective pre/post 
self-assessment was developed to evaluate the participants’ perceptions of learning and 
competence in caring for patients with calciphylaxis. A posttest was conducted to 
evaluate knowledge transfer, retention, and application of calciphylaxis principles that 
would be needed to conduct a calciphylaxis screening. The activity specific outcome 
measure assessed what changes participants could implement into practice. A shared 
enduring activity evaluation was used to evaluate the effectiveness of teaching strategies. 
Finally, an evaluation of the calciphylaxis screening tool helped examine functionality, 
usefulness, and relevance to practice. 
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Significance 
Calciphylaxis is a disease that can adversely affect the health and wellbeing of the 
affected individual. Calciphylaxis is said to affect 1% to 4% of the dialysis population 
(Brandenburg et al., 2016), but this may not be an accurate epidemiological measure (Fine 
& Zacharias, 2002; Nigwekar et al., 2014). As the nephrology community sees increasing 
numbers of ESRD patients, it is likely that there will be an increased number of 
calciphylaxis cases diagnosed. Calciphylaxis is associated with a high mortality rate 
(Parker et al., 2003; Wangen et al., 2014) and a reduced HRQOL (Jeong & Dominguez, 
2016). Yet, despite the gravity of the disease, there is very little evidence available to 
guide therapy. The evidence pointed to early recognition and treatment as being 
paramount to reducing complications and improving outcomes (Fine & Zacharias, 2002). 
The goal of this DNP project was to fill a practice gap limiting frontline dialysis staff 
from critically assessing the patient for attendant risk factors and identifying early stages 
of the disease. The ultimate outcome would be to educate frontline nurses with the 
knowledge they need to lead clinical practice change and improve health care outcomes 
for the ESRD patient.  
Summary 
The landscape of medicine was transformed by two important reports published 
by the Institute of Medicine: To Err is Human, Building a Safer Health Care System 
(1999) and Crossing the Quality Chasm: A New Health System for the 21st Century 
(2001). The onus is on health care providers to deliver safe, quality, and patient-centered 
care. Nurses are being called upon to become leaders in clinical practice and at the 
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bedside (Grindel, 2016). Nephrology nurses are ripe for assuming clinical leadership 
roles to improve outcomes for the ESRD population who are at risk of developing 
calciphylaxis.  
A calciphylaxis diagnosis comes with a high price tag in terms of patient 
outcomes, quality of life, morbidity, and mortality (Chen et al., 2016; Nigwekar et al., 
2014; Sprague, 2014). The aggressive treatments and multimodal therapy associated with 
the treatment of advanced disease often result in considerable health care costs. Routine 
calciphylaxis assessment and screening could lead to early identification and intervention 
before the development of ulcerative lesions or other systemic complications. Aggressive 
management of the disease in its early stages could ultimately save health care dollars 
and improve clinical outcomes. The development of a calciphylaxis assessment and 
screening tool and instituting routine calciphylaxis screening could be one process that 
changes the landscape of health care in nephrology through disease prevention. 
Calciphylaxis is most prevalent in the ESRD population, but it is not exclusive to 
this population. Cases have been reported in patients with chronic kidney disease, 
primary hyperparathyroidism, multiple myeloma or other plasma cell proliferative 
disorders, cirrhosis, and rheumatoid arthritis (Magro et al., 2010). This DNP project 
focused on the ESRD population, but the lessons learned can easily be applied to any of 
the vulnerable populations. 
In Section 2, I will address how Knowles’s www.amsn.org (1984; Knowles, 
Holton, & Swanson, 2005) theory of adult learning was integrated into the staff education 
project.  
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Section 2: Review of the Evidence 
Introduction 
Early recognition of calciphylaxis is paramount to early intervention and 
treatment in order to minimize complications and disease progression. A gap analysis 
found that education regarding identification of calciphylaxis wounds was necessary to 
groom dialysis providers to perform a routine calciphylaxis screening. A practice gap 
analysis found no available calciphylaxis assessment tools to inform routine screening or 
a problem-focused assessment.  
Dialysis nurses, as integral members of the interdisciplinary team, are best 
positioned to assume a leadership role at chairside and positively impact quality 
outcomes in the ESRD population. Because of the close contact between ESRD patients 
and nephrology providers, the ensuing patient–provider bond can facilitate an open two-
way communication channel. A nurse properly trained to preform calciphylaxis screening 
is in an excellent position to recognize early calciphylaxis lesions and avert the 
complications associated with advanced disease. 
The first purpose of this DNP project was to develop a calciphylaxis screening 
tool that could be used in clinical practice. The second purpose was to create a staff 
education activity that would educate dialysis nurses how to conduct a calciphylaxis 
screening and assessment in the ESRD population. This DNP project addressed two 
practice focused questions:  
1. What are the best practices based on literature evidence and expert opinion to 
be incorporated in a calciphylaxis assessment and screening tool? 
13 
 
2. Will dialysis staff who participate in a staff education activity, regarding 
calciphylaxis assessment and screening, acquire the knowledge and skills 
necessary to effectively identify calciphylaxis in the clinical setting? 
The staff education activity and draft calciphylaxis screening tool were offered to 
staff at the partner dialysis facility. While the calciphylaxis screening tool is important, it 
requires validation before it can be disseminated. Validation is expected to take place 
outside of this DNP project.  
In this section, I will discuss the application of Knowles’s (1984; Knowles et al., 
2005) theory of adult learning to the staff education activity. I will examine the gaps in 
practice that prompted this DNP project. Further, I will examine how my experiences at 
my partner organization helped to shape my role as an educator, interprofessional 
collaborator, and leader to transform care at the chairside and improve population health 
in the ESRD population. 
Concepts, Models, and Theories 
Malcolm Knowles (1913-1997) was a U.S. educator renowned for developing the 
theory of adult learning (Bates, 2009). Knowles’s first book, published in 1973, described 
the unique needs of the adult learner. This book is now in its eighth edition. Knowles 
differentiated the learning needs of children from those of the adult. Pedagogy, or the 
teaching of children, is a teacher-centric model of education (Knowles et al., 2005). 
Under a pedagogical model, the teacher determines the subject matter, the manner of 
instruction, and the evaluation methods (Knowles et al., 2005). Student participation is 
passive as the teacher leads the learning experience (Knowles et al., 2005). In contrast, 
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andragogy is defined as the “art and science of helping adults learn” (Knowles et al., 
2005, p. 61). In an andragogic model, the focus shifts from a teacher-centric emphasis on 
learning to a learner-centered approach that motivates learning. In andragogy, the role of 
the teacher shifted from leading learning to facilitating learning (Knowles et al., 2005). 
The andragogic model is based on six assumptions of adult learning (Knowles, 
1984; Knowles et al., 2005): 
 Need to know: Adult learners need a reason for learning. If knowledge 
acquisition is meaningful, then the learner will find benefit in learning. 
 Self-concept: Mature adults assume responsibility for making their own 
decisions. They become self-directed, goal directed, and independent learners. 
 Prior life experience: The varied backgrounds and experiences present in a 
group promote a “rich resource for learning” (Misch, 2002, p. 154) that can be 
capitalized upon to enhance the learning experience. 
 Motivation: Motivators for learning can include job advancement, monetary 
incentives, grades, self-improvement, self-satisfaction, or personal fulfilment.  
 Readiness to learn: Readiness to learn occurs when learning coincides with 
need-to-know situations, managing life challenges, or achieving life goals 
(Misch, 2002).  
 Relevance: Learning must be relevant and life-centered. Adult learning is 
problem centered and geared toward knowledge that is situationally applicable 
(Misch, 2002). 
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To integrate the principles of adult learning in an educational offering, the role of 
the teacher must shift to one of a process manager rather than focusing on only 
disseminating information (Knowles, 1984). Teaching strategies should be fashioned to 
facilitate participant interaction. Interactive teaching strategies could include discussion, 
case studies, work groups, brainstorming, problem solving, polling, and self-reflection. 
Such interactions tend to stimulate thinking, promote active participation, and most 
importantly can capitalize on varying life experiences of each participant. 
The application of Knowles’s andragogic principles can be applied to any adult 
learning situation whether in the live classroom, virtual classroom, distance learning, self-
study, continuing education, or human resource development. In this DNP project, 
Knowles’s theory of adult learning was used to develop an interactive staff education 
project that focused on the pathophysiology of calciphylaxis, identification of 
calciphylaxis wounds, treatment, and outcomes. While the staff education project was a 
live event, it could easily be adapted and delivered as a webinar or in an online forum. 
Relevance to Nursing Practice 
Calciphylaxis is a disease that carries a high mortality rate. Fine and Zacharias 
(2002) concluded that nonulcerating calciphylaxis carried a mortality rate of 33% at 6 
months and increased to greater than 80% with the development of ulcerative lesions. 
The findings by Fine and Zacharias suggested that nonulcerating plaque lesions likely 
represented early calciphylaxis and, if treated, could prevent progression to advanced 
disease, which is characterized by ulcerative lesions. Fine and Zacharias’s findings also 
indicated that because nonulcerative calciphylaxis is often undiagnosed or misdiagnosed, 
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the incidence of calciphylaxis is much higher than what has actually been published in 
the literature. 
The precise pathophysiology of calciphylaxis remains a mystery, but there are 
certain known risk factors. A disordered calcium and phosphorus metabolism is 
implicated as one of the leading predisposing factor to calciphylaxis (Rudolph & Lerma, 
2012). The cardiovascular disease that is seen in the ESRD population can be exacerbated 
by calciphylaxis as a result of calcium deposition in the large vessels (Chandra et al., 
2012; Magro et al., 2010) or with metastatic calcification in the myocardium (Mana, 
Sanguineti, Unterseeh, Bouvier, & Garot, 2012). A literature search produced no 
evidence of existing nursing protocols for routine calciphylaxis screening. During my 
search, I was only able to locate a single study with discussion of routine calciphylaxis 
screening. In their study, Fine and Zacharias (2002) found that most of their newly 
diagnosed calciphylaxis cases presented with dense plaques in the calf. They concluded 
that (a) nonulcerating calciphylaxis lesions were more prevalent than ulcerative lesions, 
(b) nonulcerating calciphylaxis lesions probably represented early disease, and (c) an 
experienced clinician could easily identify these calciphylaxis plaques during a routine 
screening (Fine & Zacharias, 2002). While often misdiagnosed as cellulitis, the plaques 
were often due to calcium deposition in the subcutaneous tissue, were tender on 
palpation, and could usually be seen on bone scan (Fine & Zacharias, 2002). Fine and 
Zacharias stated that they did routinely conduct screening for nonulcerative calciphylaxis 
at their peritoneal dialysis clinic. Unfortunately, they did not provide any specific 
recommendations on how to conduct a screening or offer a clinical screening instrument.  
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Despite the growing awareness of this horrific disease process, there remains 
insufficient scientific evidence to guide treatment or routine screening. But, as Fine and 
Zacharias (2002) indicated, experienced practitioners could easily identify nonulcerative 
calciphylaxis lesions with routine screenings. A nurse-driven calciphylaxis screening 
protocol conducted by nurses trained to identify nonulcerative lesions could potentially 
improve patient outcomes in patients with calciphylaxis. A screening protocol proven to 
be effective in the ESRD population could be implemented in the general population to 
screen patients at risk for developing calciphylaxis. Addressing this practice gap in the 
local ESRD population could also provide an opportunity for developing empirical data 
to inform evidence-based therapies for all patients at risk. 
Local Background and Context 
During my practicum experience, I worked with my partner facility as a member 
of the core team. The core team comprised a group of interdisciplinary professionals who 
provided direct patient care. The core team fulfilled several functions. I will review those 
that were directly applicable to my practicum experience and DNP project.  
Quality Outcome Measures 
The core team was responsible for reviewing patient and facility quality outcome 
measures as established by the Centers for Medicare & Medicaid Services (CMS). These 
quality measures are used to assess unit-specific quality and performance outcomes. They 
include dialysis adequacy, anemia management, mineral and bone disorders, nutritional 
status, infection rates, hospitalization rates, and standard mortality rates. The core team 
identified trends and developed a plan to correct any measures that did not meet goals. 
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Organizational Goals 
 Nursing staff competencies and staff retention rates were integral to good patient 
outcomes. The core team identified a problem with high staff turnover, resulting in a 
higher ratio of inexperienced nurses in relation to experienced nurses. As a result, the 
core team identified nursing education as a priority. During my tenure on the core team, I 
assumed the role of educator and presented on topics such as fall prevention, adverse 
drug events, and medication nonadherence. These presentations were also developed 
using a Knowles’s framework. 
According to Chaghari, Saffari, Ebadi, and Ameryoun (2017), staff education is 
necessary to maintain core competencies, quality outcomes, patient outcomes, and job 
satisfaction. Staff education in nursing can help strengthen the health care organization 
by improving employee productivity, fostering innovative thinking, improving patient 
outcomes through best clinical practices, and stimulating a desire for lifelong learning 
(Chaghari et al., 2017). In the case at hand, dialysis staff was motivated to learn how to 
apply evidence-based principles and transform care at the bedside to improve patient 
outcomes. They were able to immediately apply what they learned to problems 
encountered in clinical practice. This resulted in increasing self-confidence building 
skills. Increased self-confidence leads to job security, job satisfaction, and ultimately staff 
retention. 
Calciphylaxis as a Focus for my DNP Project 
The core team identified a trend in the increasing number of patients with 
calciphylaxis. Patients with calciphylaxis require an aggressive multimodal and 
19 
 
multidisciplinary treatment plan. Treatments can include (a) increasing the dialysis time 
and frequency, (b) managing serum phosphate levels using one or more phosphate 
binders, (c) suppressing the parathyroid gland with calcimimetics and bisphosphonates, 
(d) preventing hypercalcemia by limiting exposure to extrinsic calcium and vitamin D, 
(e) administering intravenous sodium thiosulfate to chelate calcium deposits in the 
subcutaneous tissue, and (f) managing pain. If indicated, surgical interventions could 
include parathyroidectomy for hyperparathyroidism and wound debridement to facilitate 
wound healing. Adjuvant hyperbaric oxygen therapy has also been used for wound 
healing. Patients with calciphylaxis are often comanaged by specialists in infectious 
disease, wound care, and pain management. Calciphylaxis can negatively impact a 
number of the quality outcome measures set out by CMS. Calciphylaxis screenings are 
not typically performed, and in my literature review I was unable to uncover any 
validated clinical assessments available to conduct a routine calciphylaxis screening. To 
address this practice gap, I developed a calciphylaxis assessment and screening tool that 
could be used in clinical practice.  
Despite all that is known about the devastating effects of calciphylaxis, there 
remains a practice void and absence of tools to effectively screen patients for 
calciphylaxis. This DNP project was one approach in bridging the local calciphylaxis 
knowledge gap and could potentially address the knowledge and practice gaps identified 
in the nephrology community at large.  
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Role of the DNP Student 
As a nurse practitioner practicing in the outpatient hemodialysis setting, I found 
an increased incidence of advanced ulcerative calciphylaxis cases being diagnosed 
outside of the dialysis unit. This prompted a question of why calciphylaxis was not 
recognized in the dialysis setting. Two themes came to light. First, dialysis staff was not 
looking for calciphylaxis and second, dialysis nurses were not prepared to identify 
calciphylaxis wounds or conduct routine screenings for calciphylaxis. 
Patients who reach advanced stages of calciphylaxis have poorer outcomes and 
higher mortality rates. To improve outcomes, calciphylaxis needs to be diagnosed in its 
early stages. Most hemodialysis patients receive treatments several times a week. This 
frequent contact puts dialysis professionals in the best position to screen for early 
manifestations of the disease. Currently, dialysis nurses conduct monthly foot inspections 
in their diabetic patients and a monthly pain assessment on all patients. Calciphylaxis 
management should become an integral part of dialysis care and should start with routine 
screenings. A calciphylaxis screening program could be implemented without a 
significant disruption in nursing workload and for a minimal cost simply by building 
upon the diabetic foot exam and pain assessment. My proposal to design a calciphylaxis 
screening tool and develop a contemporaneous staff education program has the potential 
to improve patient outcomes, reduce calciphylaxis-related hospitalization, and reduce 
health care spending. 
My role as the DNP student was to develop the screening tool and the staff 
education project. I designed the education to include the topics of calciphylaxis 
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pathophysiology, individual risk factor assessment, typical skin changes, staging of 
lesions, treatment strategies, and pain assessment. I stressed the role of nurse leader to 
effectively transform care at the chairside and to spearhead practice changes that could 
improve outcomes subsequent to disease prevention. Several evaluation methods were 
employed to determine knowledge transfer and application to nursing practice. These are 
fully discussed in Section 4.  
Summary 
While previously under recognized, the burden of calciphylaxis is now coming to 
the forefront. Calciphylaxis is a fatal disease. More research is needed to determine if a 
nurse-driven calciphylaxis screening program could improve calciphylaxis-related 
outcomes, but first nurses need the tools to accomplish this task. A logical source in 
which to find such screening tools should be in the published literature. However, a 
diligent search revealed that there was little to no relevant material available. Therefore, 
it became necessary to develop a calciphylaxis screening tool from the ground up. No 
matter how effective or successful this tool may be, it is useless in the hands of an 
untrained provider. Therefore, provider education plays an integral part in calciphylaxis 
management. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
Calciphylaxis is a disease frequently referenced in literature, but it has been 
poorly studied and there is little evidence to inform practice. One message consistently 
threaded throughout the literature was that early identification and treatment of 
calciphylaxis is paramount to improved patient outcomes and quality of life. There was 
no evidence to inform recommendations for routine screening. Fine and Zacharias (2002) 
found that calciphylaxis was nonulcerative in the early stages and could be identified 
through routine screening. Fine and Zacharias indicated that routine screenings were 
performed in their peritoneal dialysis patients. Unfortunately, Fine and Zacharias did not 
provide any information regarding how to screen for the disease nor did they provide a 
screening tool. Despite this evidence, now 15 years later, best practices are still lacking. 
This DNP project focused on two objectives. The first objective was to design an 
evidence-based calciphylaxis screening and assessment tool that could be used in clinical 
practice to inform routine calciphylaxis screenings in the ESRD population. The second 
objective was to develop a staff education activity to provide dialysis nurses with the 
baseline knowledge that would enable them to screen for early calciphylaxis and identify 
nonulcerative calciphylaxis lesions. 
A literature search failed to produce any existing calciphylaxis screening 
instrument. There were no randomized control trials, systematic reviews, or clinical 
practice guidelines to inform a calciphylaxis screening. Therefore, I needed to design a 
screening instrument from the ground up. To determine best evidence to be included in a 
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calciphylaxis screening tool, I had to rely on general search terms to locate data and 
design a calciphylaxis screening tool.  
In this section, I review evidence regarding wound management, screening for 
diabetic Charcot foot, foot assessment in the dialysis patient, and pain assessments. Such 
topics laid the groundwork for developing the calciphylaxis screening instrument. I was 
then able to use the tool as a template to inform the staff education project and educate 
dialysis nurses to conduct a calciphylaxis screening.  
Practice-Focused Questions 
This DNP project addressed two practice focused questions:  
1. What are the best practices based on literature evidence and expert opinion to 
be incorporated in a calciphylaxis assessment and screening tool? 
2. Will dialysis staff who participate in a staff education activity, regarding 
calciphylaxis assessment and screening, acquire the knowledge and skills 
necessary to effectively identify calciphylaxis in the clinical setting? 
The nephrology community has agreed that calciphylaxis is a population health 
concern. Unfortunately, there has been very limited evidence to guide screening, 
evaluation, or treatment. Nephrology nurses with the proper training and assessment tool 
could be positioned to assume a leadership role, proactively perform a calciphylaxis 
screening, and make appropriate referrals for medical management. 
The purpose of this DNP project was to address gaps in practice and knowledge 
and improve clinical outcomes through staff education. Using Knowles’s (1984; Knowles 
et al., 2005) model of andragogy as the theoretical framework, nursing staff were 
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educated on calciphylaxis prevention, screening, identification of early calciphylaxis 
lesions. 
Sources of Evidence 
A literature search was conducted electronically using the Walden University 
Library, University of New York at Buffalo Library, and a general Internet search. 
Databases searched included EBSCO, Medline, CINAHL, ProQuest, Thoreau, Google 
Scholar, Google, and the American Nephrology Nurses Association online library. 
Search terms included nursing protocol, skin care protocol, ulcers, diabetic ulcers, 
wounds, wound assessment, wound management, skin lesions, dermatology, 
calciphylaxis, calcific uremic arteriolopathy, CUA, non-uremic calciphylaxis, metastatic 
calcification, panniculitis, end-stage renal disease, renal failure, chronic kidney disease, 
ESRD, calciphylaxis pain assessment, and pain assessment. In addition, I queried the 
American Nephrology Nurses Association ANNA Connected Advanced Practice 
Specialty Practice Network regarding any existing nursing protocols for the early 
recognition of calciphylaxis lesions. This query failed to produce any existing nursing 
protocols, making this uncharted territory. 
Russo et al. (2015) underscored the importance of early diagnosis and found 
calciphylaxis is undiagnosed in its early stages. Rather, calciphylaxis is usually diagnosed 
in the late stage following the development of cutaneous ulcers. The ensuing multimodal 
therapy can include medical wound care, surgical wound care, off-label use of sodium 
thiosulfate, cinacalcet, hyperbaric oxygen therapy, and parathyroidectomy (Russo et al., 
2015). In my clinical practice, treatment also included an increase in dialysis frequency, 
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aggressive reduction in serum phosphorus utilizing multiple phosphate binders, use of 
bisphosphonates, frequent laboratory monitoring, and often an infectious disease referral. 
The cost associated with multimodal therapy in terms of HRQOL, morbidity and 
mortality, health care costs, and clinical outcomes can be nothing more than staggering. 
Burdette-Taylor (2015) reported an annual cost of $1.6 billion for the care of new 
diabetic foot ulcers and as high as $6 billion inclusive of prior ulcer care. It is 
conceivable that these costs pale in comparison with expenditures related to calciphylaxis 
multimodal therapy. Burdette-Taylor’s teachings regarding proactive interventions 
focused on preventing diabetic ulcers are undeniably applicable to the ESRD population 
and calciphylaxis screening. 
Feeser (2011) stated, “[p]revention and early diagnosis are essential to successful 
management of CUA. Once ulcers develop, there is a dramatic twofold increase in 
mortality, strongly suggesting that all possible means should be employed in an attempt 
to prevent ulceration” (p. 381). A diagnosis of calciphylaxis is often based on clinical 
presentation and patient history (Feeser, 2011). Cutaneous biopsy is the gold standard for 
diagnosis, but the biopsy itself can lead to complications such as ulceration, infection 
(Feeser, 2011), and poor wound healing of the biopsy site (Wheeler & Singh, 2008). In 
actual practice, it has been my experience that health care providers avoid cutaneous 
biopsy for these exact reasons. There are several noninvasive studies (plain radiograph, 
xeroradiography, soft tissue mammogram, ultrasound, and computerized tomography) 
available that can be used to screen for vessel calcification and provide a clinical picture 
supporting a diagnosis of nonulcerative calciphylaxis (Feeser, 2011). Wheeler and Singh 
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(2008) examined the use of a bone scan to identify soft tissue calcifications as another 
noninvasive diagnostic that can confirm a clinical suspicion of early onset calciphylaxis.  
The literature search failed to produce any nursing protocols that specifically 
addressed identification of early onset calciphylaxis. For that reason, I searched for 
information regarding nursing protocols that addressed wound surveillance in diabetic 
wounds and conducting a meaningful pain assessment. The theoretical underpinnings of 
these disease processes could be applied to a calciphylaxis specific assessment and 
screening tool. 
Burdette-Taylor (2015) stressed a proactive approach for the assessment, early 
identification, and intervention of diabetic patient with lower extremity arterial disease 
and lower extremity neuropathic disease. Burdette-Taylor proposed a model to utilize 
certified foot and nail care nurses to conduct regular basic foot and lower extremity 
examinations for the early identification and treatment of diabetic foot ulcers. While 
Burdette-Taylor did not provide any hard evidence to validate the model, the concept of 
being proactive can lead to early identification and timely intervention, which can 
improve health outcomes and quality of life. 
The 1st Consensus Conference on CUA convened in Leuven, Belgium on 
September 25, 2015. Thirteen experts in the field of calciphylaxis joined together to form 
a consensus opinion regarding standards that could be applied in the prevention, 
identification, and treatment of calciphylaxis (Brandenburg et al., 2016). Several 
important opinions emerged that are directly applicable to this project and are outlined 
below (Brandenburg et al., 2016) and were incorporated in the staff education activity: 
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 The presence of painful lesions in a setting of ESRD and/or other risk factors 
should raise a high suspicion for calciphylaxis. 
 Common findings in calciphylaxis include pain and firm calcified lesions that 
are palpated in the subcutaneous tissues. 
 Many providers lack the knowledge and skills necessary to identify the early 
signs of calciphylaxis. 
 The use of warfarin is associated with the development of calciphylaxis. 
 Calcium loading and hyperphosphatemia are not necessarily predictors of 
calciphylaxis. 
 Patients who develop large calciphylaxis lesions have the worst prognosis. 
Foot Assessments 
I was able to locate two existing DNP projects that could inform development of 
the calciphylaxis assessment and screening tool. 
Robertson (2013) identified lower extremity amputations in the ESRD population 
as a population health problem. To address this problem, Robertson developed a lower 
extremity algorithm to guide lower extremity assessment. A short 3-month pilot study 
was conducted using the algorithm. Interestingly, by the second month, the patients were 
asking staff to assess their feet and actively participated in the exam. The Robertson 
study was limited in respect to sample size and study period. There were no correlations 
made between the foot assessments and referrals. Despite these limitations, it seemed that 
the foot algorithm served to educate and engage patients to participate in self-care 
(Robertson, 2013). Robertson also commented that, following the 3-month trial, the 
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algorithm was adopted by the dialysis facility for inclusion in their monthly foot 
assessment protocol. 
Wade (2016) developed an assessment and screening tool to be used by nurse 
practitioners in identifying Charcot foot. The tool was developed but not implemented 
and therefore utility of the tool was not studied. The tool was validated by two expert 
reviewers and Wade disseminated the information among a limited number of nurse 
practitioners. Although there has been no evidence supporting actual utility of the tool, I 
used it as a model to design the calciphylaxis assessment and screening tool in this DNP 
project.  
Wound Management Protocols 
Catania, Huang, Madison, Moran, and Ohr (2007) discussed how a cancer 
hospital improved pressure ulcer quality indicators by engaging and empowering the 
clinical team to implement a pressure ulcer prevention protocol intervention (PUPPI). 
Prior to implementing the PUPPI, an initial 2003 survey reported a prevalence rate of 
19.47% for all ulcers and 12.39% for hospital acquired ulcers (n = 113). National 
Database of Nursing Quality Indicators (NDNQI) benchmarks at that time were 12.65% 
and 6.84% respectively (Catania et al., 2007). These nurse sensitive indicators exceeded 
the national benchmarks by > 50%. Initial efforts to improve pressure ulcer management 
were marginally effective (Catania et al., 2007). These improvements, however, proved 
to be short lived. After forming a quality improvement (QI) team, a root cause analysis 
showed that nursing staff were not fully on board with the intervention. Nursing 
implicated a lack of specialty equipment and skin care products (Catania et al., 2007). 
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Further analysis by the QI team found inconsistencies in nursing assessments and 
documentation that contributed to the poorer outcomes. With this knowledge in hand, the 
QI team implemented strategies to engage the nursing staff in this quality improvement 
initiative (Catania et al., 2007). In addition, the team evaluated the organizational 
commitment to improvement. The resultant PUPPI incorporated specialty patient care 
equipment, developed a nurse-driven protocol intervention, actively engaged patient care 
technicians who provided direct patient care, incorporated weekly monitoring, and 
integrated staff education (Catania et al., 2007). Following implementation of the PUPPI 
in September 2004, the hospital realized quality indicators that were well below NDNQI 
benchmarks. The study reported outcomes into June 2006. During the report period, not 
only did NDNQI benchmarks fall, but so did the hospital’s prevalence data (Catania et 
al., 2007). This study underscores that protocols in and of themselves are not enough to 
bring about change. Stakeholders must be empowered through education, teamwork, and 
organizational commitment.  
Aalaa, Malazy, Peimani, and Mohajeri-Tehrani (2012) found that 85% of lower 
extremity amputations in diabetics could be prevented with routine nurse-driven patient 
education, routine screening, and early intervention of identified diabetic foot 
complications. The authors stressed that “education of health care provider is a crucial 
issue” (Aalaa et al., 2012, “Nurse’s Role in Education,” para. 4). 
Pain Assessment 
Acute and chronic pain has been described as prevalent in the ESRD population, 
which can negatively affect an individual’s quality of life. Brkovic, Burilovic, and Puljak 
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(2016) conducted a systematic review of pain in the hemodialysis population and found 
that causes for pain in this population are multifactorial. The authors found that 82% of 
participants suffered with acute pain and 92% suffered with chronic pain (Brkovic et al., 
2016). Davison (2007) recognized that the presence of “extremely painful, well-
demarcated nonulcerating plaques” (p. 1278) could represent early calciphylaxis. If left 
untreated, these wounds could develop into the cutaneous ulcerations seen in progressive 
disease. This indicates that the pain associated with calciphylaxis is an important 
symptom and that an accurate pain assessment is integral to calciphylaxis screening. 
Farahani, Alhani, and Mohammadi (2014) conducted a study to evaluate the pain 
assessment skills of pediatric nurses. Pain assessment in pediatrics can be challenging as 
infants may not be able to communicate their pain, or young children may not accurately 
communicate pain (Farahani et al., 2014). The researchers conducted a quasi-
experimental study to determine if a pain committee improved nursing skill sets in pain 
evaluation, assessment, and management. The initial needs assessment revealed that, in 
general, nurses lacked the knowledge to conduct a systematic pain evaluation (Farahani 
et al., 2014). To address this knowledge gap, the researches convened a pain committee 
charged with educating the nurses how to conduct a systematic pain assessment. 
Following implementation of the pain committee, statistical analysis indicated nurses in 
the intervention group possessed superior assessment skills as compared to the nurses in 
the control group (P ≤ 0.001) (Farahani, 2014). 
The lessons learned from the Farahani et al. (2014) study are applicable to the 
dialysis population. As Brkovic et al. (2016) noted, acute and chronic pain is prevalent in 
31 
 
the hemodialysis population. The multifactorial nature of pain can make pain assessment 
an arduous process. Pain is recognized as the fifth vital sign by the American Pain 
Society (Farahani et al., 2014). As the fifth vital sign, it is imperative that dialysis nurses 
possess a strong pain assessment skill-set as part of the calciphylaxis screening. 
Evidence Generated for Doctoral Project 
The staff education project was the focus of this DNP project. I obtained site 
specific approval to conduct my research at my partner dialysis facility. Approval at the 
partner dialysis facility was granted to include 25 dialysis staff members in the study.  
Participants 
The number of participants was based on the number of staff working at the unit. 
There were no exclusion criteria. Registered nurses and advanced practice nurses would 
exclusively conduct routine screenings. Other interdisciplinary team members could 
provide education on topics such as dietary management, reduction of complications, 
wound care, smoking cessation, and reporting of symptoms. Calciphylaxis management 
could be integrated into the interdisciplinary patient care plan of care. Each dialysis staff 
member plays an important role in calciphylaxis management and therefore all staff 
members were included in the participant pool. 
Recruitment of study participants was accomplished through flyers posted within 
the dialysis unit. I also extended personal invitations to nurse practitioners who were 
credentialed at the partner dialysis facility. Scheduling of the educational activity was 
flexible to accommodate staff schedules and maximize staff participation with minimal 
disruption in unit activity or patient care.  
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Procedures 
Any interested dialysis staff member was eligible to participate in the study. 
Continuing education credits were provided through Walden University. In order to claim 
continuing education credits the participants were required to attend the entire live 
presentation, sign on to the website, achieve a passing score on the posttest, complete an 
activity specific outcome measure, and complete a shared enduring activity evaluation. In 
addition, participants were asked to complete two paper based evaluations following the 
live presentation, a retrospective pre/post self-evaluation and an evaluation of the 
calciphylaxis assessment and screening tool. 
Posttest. The posttest was a method of evaluation to obtain subjective data 
regarding knowledge transfer and retention that occurred following the staff education 
project. It was completed online and participants were required to obtain a score of 80% 
to pass. 
Activity specific outcome measure. The activity specific outcome measure 
determined what changes the participants could implement into practice that would foster 
sustainability and improved patient outcomes. This was completed online and was 
required to claim continuing education credit. 
Activity evaluation. An activity evaluation was required to claim continuing 
education credit. The activity evaluation assessed the effectiveness of the teaching 
strategies and provided insight program effectiveness. The feedback obtained can be used 
to guide future educational activities. 
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Retrospective pre/post self-evaluation.  I chose the retrospective pre/post self-
evaluation to assess the participants’ subjective perception of competence in managing 
calciphylaxis. The retrospective pre/post self-evaluation tool is a validated method for 
assessing subjective data. Because this was a blinded study I was not able to conduct a 
standard pre/post evaluation designed to measure change as a resulting from staff 
education. 
Calciphylaxis screening and assessment tool evaluation. This was a paper 
based evaluation that was conducted immediately following the live presentation. I used 
this evaluation as a means to determine the screening tool’s usefulness, functionality, and 
relevance to practice. I also used the evaluation to elicit feedback for improvements and 
enhancements to revise the tool. 
Protections 
I structured my DNP project as a single center, blinded, quasi-experimental 
design. Approval was obtained through Walden University Investigational Review 
Board. Because of the nature of the study, a signed consent was not required. Participant 
anonymity was required by Walden and also by the partner site. All staff members were 
provided with a copy of the consent prior to the start of the educational activity. The 
consent was reviewed at the beginning of the PowerPoint presentation and an electronic 
version of the consent was posted on the online platform. Following the live presentation 
the participants were asked to complete the paper based evaluations in my absence. One 
participant was designated to collect the completed evaluations and place them in a 
manila envelope for delivery to the DNP student. Additional evaluations were completed 
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on the online continuing education platform, which was administered by the director of 
continuing nurse education at Walden University. This director provided me with the raw 
data that was collected while the online platform was active. In this way, participant 
anonymity was maintained. 
Participants were advised that all project activities were voluntary. Conversely 
certain assessments were mandatory for claiming continuing education credits. In this 
instance, participants were assured that raw data would be collected in a manner that 
maintained anonymity. 
Analysis and Synthesis 
The project began by designing a calciphylaxis assessment and screening tool 
based on the literature evidence and expert opinion. The tool was divided into three 
sections: (a) a calciphylaxis risk assessment, (b) a multidimensional pain assessment 
using the PEG pain scale, and (c) a skin assessment diagram. I then developed an 
educational program and presented this at the partner dialysis site. Utilizing Knowles’s 
(1984; Knowles et al., 2005) framework, the educational component focused on the 
pathophysiology of calciphylaxis, risk factor identification, wound identification, and 
application of the assessment tool in clinical practice. The effectiveness of the education 
program was evaluated through a series of assessments to determine knowledge transfer, 
the participant’s objective assessment of competence in calciphylaxis management, 
strategies for implementing and sustaining change, and finally the feasibility to 
implement calciphylaxis screening in clinical practice. 
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Summary 
I conducted a literature search that failed to produce any nursing protocols 
specific to the early identification of calciphylaxis or for conducting a routine 
calciphylaxis screening. Yet, calciphylaxis remains a significant health care challenge for 
the ESRD population. The concepts related to skin breakdown and diabetic foot ulcers 
were applicable to caring for the patient with calciphylaxis. Research in these areas 
revealed a benefit to screening and nurse-driven protocols that could easily be integrated 
into a calciphylaxis screening protocol. Successful implementation of a calciphylaxis 
screening protocol will be dependent upon knowledgeable providers with the skill sets to 
effectively conduct comprehensive assessments. To address the practice gap, I designed a 
calciphylaxis screening tool that could be implemented into clinical practice. The tool has 
yet to be validated. Validation is expected to take place outside of the DNP project.  
Calciphylaxis is a deadly disease. There is a need for generating evidence that can 
be applied to clinical practice and transform care delivery for patients with calciphylaxis.  
In this project, I proposed that calciphylaxis screenings could easily be integrated into 
practice by building upon current foot and pain assessments. This could easily be 
accomplished with minimal disruption to workflow or interruptions in patient care. I have 
addressed the practice and knowledge gaps that would act as barriers to implementation. 
Implementation of a calciphylaxis screening has the potential to transform care at the 
chairside by applying evidence to improve outcomes in the ESRD population and other 
vulnerable populations. 
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I sought to determine if a staff education activity would provide dialysis nurses 
with the knowledge and skills necessary to identify calciphylaxis in the clinical setting. In 
Section 4 I analyzed the data to determine the answer to this question. 
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Section 4: Findings and Recommendations 
Introduction 
Calciphylaxis is estimated to affect 1% to 4% of the ESRD population 
(Brandenburg et al., 2016). Poor outcomes and high mortality rates are associated with 
calciphylaxis. Research uncovered an abundance of literature describing risk factors, case 
studies, recommendations for treatment, and disease trajectories. The one predominant 
theme threaded throughout the literature was that patients experience improved outcomes 
if the health care provider diagnoses calciphylaxis in the early stages and initiates 
treatment prior to the development of ulcerative lesions. While literature supported 
routine screening for calciphylaxis, there were no nursing protocols, guidelines, or 
clinical instruments that informed routine screening.  
One challenge seen in health care models today is the transformation of health 
care delivery from treatment to prevention (Ronco, Mason, Karopadi, Milburn, & 
Hegbrant, 2014). This DNP project focused on calciphylaxis prevention developing a 
screening tool and a staff education program. The goal of the educational activity was to 
educate dialysis staff about risk factors, pathogenesis, pain assessment, and wound 
identification. Ultimately, dialysis staff should be able to use this knowledge to 
implement a screening protocol and calciphylaxis management program in clinical 
practice.  
Calciphylaxis Screening Tool 
 Despite an exhaustive literature search and reaching out to other nephrology 
providers, I was not able to discern any evidence to guide a routine calciphylaxis 
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screening. Likewise, I was unable to discover any nursing protocols or existing screening 
instruments. My research found considerable evidence to support screenings for diabetic 
wounds, pressure ulcers, and other skin breakdown. Aalaa et al. (2012) found that nurse-
driven protocols, routine screenings, and early intervention could significantly reduce the 
number of lower extremity amputations in the diabetic population. The nephrology 
community is lagging in calciphylaxis wound screening, early intervention, and disease 
prevention. It is time that the nephrology community fills this practice void. Designing a 
calciphylaxis screening instrument can be one avenue to address this void.  
The 1st Consensus Conference on CUA opined that many nephrology providers 
lack the knowledge and skills necessary to identify early signs of calciphylaxis 
(Brandenburg et al., 2016). Any screening instrument lacks value if the provider using it 
lacks a fundamental knowledge of the underlying disease process. For this reason, an 
important aspect of this DNP project was not only to design the screening tool, but also to 
provide dialysis staff with a foundation to use the assessment form effectively in clinical 
practice.  
Pain and metastatic calcifications with or without skin ulceration are hallmark 
signs of calciphylaxis. The assessment tool focuses on three key aspects in calciphylaxis 
pathogenesis: (a) risk factors, (b) a multidimensional pain assessment, and (c) wound 
identification. In developing the tool, I was cognizant of the fact that a potential barrier 
existed if routine calciphylaxis screenings proved to be burdensome or disrupted unit 
workflow. With this in mind, I fashioned a screening tool that capitalized on an 
opportunity to expand the current practice of monthly diabetic foot exams and pain 
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assessments. After the original design was completed, the screening tool was introduced 
during a staff education activity. The participants were asked to evaluate the tool on its 
general format, content, relevance to practice, and functionality. Any suggestions for 
improvements were incorporated into the final tool (Appendix A). I revised the tool based 
on participant suggestions. The tool requires validation before it can be placed into 
clinical practice. 
Staff Education Program 
The primary study was approved by the IRB at Walden University (Approval 
Number 06-21-17-0103266). I received formal approval from the clinical research 
department at my partner dialysis organization and collected data from dialysis staff for 
this project. The project was a single center, blinded, quasi-experimental, mixed method 
design. The research question was as follows: Will dialysis staff who participate in a staff 
education activity regarding calciphylaxis assessment and screening acquire the 
knowledge and skills necessary to effectively identify calciphylaxis lesions in the clinical 
setting? The staff education activity, titled “Calciphylaxis: The Dialysis Medusa,” offered 
1.5 continuing education contact hours, including 1.5 hours of pharmacology content 
through Walden University, an American Nurses Credentialing Center–approved 
provider. Inclusion criteria were broad and included anyone interested in learning about 
calciphylaxis. There were no exclusion criteria. To claim contact hours, participants were 
required to (a) attend the entire live presentation; (b) sign on to an activity-specific 
website by November 3, 2017 to complete a posttest, answer an activity specific outcome 
measure evaluation, and complete the shared enduring activity evaluation. Participants 
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were required to achieve a score of 80% on the posttest and were afforded three 
opportunities for successful completion. The website was administered by the director of 
clinical nurse education at Walden University. 
The Live Activity 
Working in conjunction with the director of continuing nurse education at Walden 
University, we developed the continuing education activity in accordance with the 
accredited provider planning template and educational planning table (Appendix B). 
Once finalized, I presented the program dialysis staff at the partner dialysis facility. The 
PowerPoint deck that I prepared appears in Appendix C. Content included the history of 
calciphylaxis, pathogenesis, cutaneous calciphylaxis, systemic calciphylaxis, 
identification of lesions, treatment of calciphylaxis, assessment and disease prevention. I 
designed the education to be interactive using Knowles’s (1984; Knowles et al., 2005) 
assumptions of adult learning. I scheduled six separate sessions to accommodate the staff 
schedules and maximize the participant pool. Each session lasted about 1.5 hours. There 
were a total of 26 participants who attended from all job classifications. This was a 
student-centered activity and I fostered student engagement by including interactive case 
discussions, risk factor identification, question periods, wound identification exercises, 
risk factor identification, case study analyses, and incorporated participant lived 
experiences in caring for patients with calciphylaxis.  
Although assessments, such as screening for calciphylaxis, are typically within 
the scope of practice of the registered nurse, I opted to include any member of the 
interdisciplinary team in the training. According to Nancarrow et al. (2013), the 
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interdisciplinary team includes all professional and nonprofessional staff. The 
interdisciplinary team collaborates and brings individual and disciplinary attributes for 
the improvement of patient care. The dynamics of the interdisciplinary team include 
communication, respect, vision, a shared mental model, and the delivery of patient-
focused care (Nancarrow et al., 2013). It is for these reasons that I encouraged all 
members of the dialysis team to participate in this education project. The interdisciplinary 
team breakdown can be seen in Table 1; registered nurses included 54% of the 
participants.  
Table 1 
 
Participant Breakdown 
 Number of 
Participants 
Percentage 
Nurse Practitioners 2 7.7% 
Registered Nurses 14 53.8% 
Licensed Practical Nurses 2 7.7% 
Patient Care Technicians 2 7.7% 
Social Workers 2 7.7% 
Dieticians 2 7.7% 
Administrative Assistants 2 7.7% 
 
In addition to the live presentation, there was a website created and administered 
by the director of continuing nurse education at Walden University. This website was 
created for participants to apply for continuing education credits. Participants were 
required to attest to attending the entire live presentation, achieve a score of 80% on a 
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posttest, answer an activity specific/outcome measure evaluation, and complete an 
activity evaluation in order to claim for continuing education credit. The online platform 
was active from October 4, 2017 to November 3, 2017. A total of 23 participants signed 
on to the website. Sixteen participants completed the posttest. Twelve participants 
completed all requirements and claimed continuing education credit.  
Evaluation of the Educational Activity 
I used several evaluation strategies to determine if participants acquired the 
knowledge to identify calciphylaxis lesions and to evaluate the effectiveness of teaching 
strategies. 
Retrospective pre/post self-assessment. The retrospective pre/post assessment 
has been found to be an effective method to evaluate learning and knowledge transfer 
(Bhanji, Gottesman, de Grave, Steinert, & Winer, 2012). I administered the retrospective 
pre/post self-assessment following the live presentation. I used this evaluation to 
determine if the participants perceived learning occurred and if they felt confident 
applying their new knowledge in the clinical setting. I manually entered participant 
responses into the electronic equivalent survey design created online at Survey Monkey 
for further analysis. 
Posttest. The posttest evaluated knowledge transfer, retention, the application of 
calciphylaxis principles, and wound identification. The test comprised 21 questions 
covering topics such as pathophysiology; diagnostic criteria; types and stages of 
calciphylaxis lesions; systemic calciphylaxis; pharmacological and nonpharmacological 
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therapies; and pain assessment. The posttest was administered via the online platform. 
The posttest was required to claim continuing education credit 
Activity-specific/outcome measure evaluation. The online activity-specific 
outcome measure was designed to determine (a) if participants acquired knowledge that 
could be applied to assess, identify, and implement procedures that may improve 
outcomes for patients with calciphylaxis, and (b) if participants would implement 
changes to their practice after attending the educational activity. This evaluation was a 
requirement to claim continuing education credit 
Shared enduring activity evaluation. Finally, participants completed the share 
enduring activity evaluation via the online platform. This evaluation was a requirement to 
claim continuing education credit. 
Evaluation of the Calciphylaxis Screening Tool 
I introduced the initial calciphylaxis screening tool during the educational 
activity. Following the presentation, participants were asked to complete a paper based 
evaluation of the tool. The evaluation consisted of 10 questions focusing on general 
appearance, functionality, usability, relevance to practice, anticipated barriers to 
implementation, and an overall rating. I manually entered participant responses into the 
electronic equivalent survey created online at Survey Monkey for further analysis. 
Findings and Implications 
Calciphylaxis is a disease process that has far reaching implications for 
individuals and the health care system. Calciphylaxis is associated with a high mortality 
rate and has a negative impact on the patients’ HRQOL. The multimodal therapies can 
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result in considerable health care expenditures. Yet, as Fine and Zacharias (2002) 
concluded, there is a high prevalence of nonulcerative calciphylaxis that goes 
undiagnosed, which ideally could be identified with routine screening. Despite their 
supposition, 15 years later, there still remains a practice void in terms of calciphylaxis 
screening. This DNP project may provide the means for health care transformation from 
treatment to prevention. 
As discussed above, I conducted several assessments and evaluations throughout 
the project. I detailed the findings of each assessment below. 
Retrospective Pre/Post Self-Assessment 
The retrospective pre/post self-assessment comprised 14 questions. Participants 
were asked to evaluate their baseline knowledge and comfort level subjectively prior to 
attending the staff education activity. They then compared these answers with their 
subjective feelings of learning and competence in identifying calciphylaxis following the 
educational activity. Tables 2 to 8 outline participant responses. Overall, there seemed to 
be a subjective increase in functional knowledge and feelings of confidence following the 
live activity. 
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Table 2 
 
Pre/Post Self-Assessment: Response to Questions 1 and 2 
Question 1: Describe your level of 
knowledge about calciphylaxis 
PRIOR to attending this presentation. 
 Question 2: Describe your level of knowledge 
about calciphylaxis AFTER attending this 
presentation. 
Answer Choice Number Percent  Answer Choice Number Percent 
I never heard of it. 0 0%  I learned nothing new. 0 0% 
I’ve heard of it, but I 
don’t know much 
about it. 
8 32% 
 
I learned some new 
information about the disease. 
2 8% 
I’ve taken care of a 
patient with 
calciphylaxis, but I 
don’t understand much 
about the disease. 
4 16% 
 
I have a better understanding 
of the disease, but I am NOT 
comfortable caring for a 
patient with calciphylaxis. 
1 4% 
I’ve taken care of a 
patient with 
calciphylaxis and I 
have some 
understanding of the 
disease. 
13 52% 
 
I think I can take care of a 
patient with calciphylaxis. 
1 4% 
I’ve never taken care 
of a patient with 
calciphylaxis, but I 
have some 
understanding of the 
disease. 
0 0% 
 
I have a better understanding 
of the disease and I am 
comfortable caring for a 
patient with calciphylaxis. 
20 80% 
I have advanced 
knowledge. 
0 0% 
 I had advanced knowledge of 
the disease, but I did learn 
some things that I did not 
know previously. 
1 4% 
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From the responses above, prior to attending the educational activity, only 52% of 
participants stated they had some understanding of calciphylaxis. However, after 
attending the educational activity, 80% of participants felt they had a better 
understanding of the disease and could care for a patient with calciphylaxis. Only one 
participant (4%) felt she did not acquire enough knowledge to care for a patient with 
calciphylaxis.  
The next few sets of questions (see Tables 3, 4, and 5) queried how comfortable 
participants felt in identifying patients at risk for developing calciphylaxis and their 
comfort levels in identifying different stages of calciphylaxis lesions.  
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Table 3 
 
Pre/Post Self-Assessment: Comparison Between Questions 3 and 4 
Answer 
choices 
Question 3: Describe how 
comfortable you were at 
identifying patients at risk of 
developing calciphylaxis 
PRIOR to attending this 
presentation. 
 
Question 4: Describe how 
comfortable you feel you are at 
identifying patients at risk of 
developing calciphylaxis AFTER 
attending this presentation. 
 Response Percent  Response Percent 
 
Not at all. 
15 60%  0 0% 
 
A little 
comfortable. 
7 28%  6 24% 
 
Very 
comfortable. 
3 12%  17 68% 
 
I am very 
knowledgeable. 
0 0%  2 8% 
 
Sixty percent of participants were not at all comfortable identifying patients at 
risk of developing calciphylaxis prior to attending the presentation. Following the 
presentation 68% of participants felt “very comfortable,” an increase of 82.3%. 
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Table 4 
 
Pre/Post Self-Assessment: Comparison Between Questions 5 and 6 
Answer 
choices 
Question 5: Describe how 
comfortable you were at 
identifying nonulcerative 
calciphylaxis lesions PRIOR to 
attending this presentation 
 
Question 6: Describe how 
comfortable you feel you are at 
identifying nonulcerative 
calciphylaxis lesions AFTER 
attending this presentation 
 Response Percent  Response Percent 
 
Not at all. 16 64%  1 4% 
 
A little 
comfortable. 
8 32%  8 32% 
 
Very 
comfortable. 
1 4%  14 56% 
 
I am very 
knowledgeable. 
0 0%  2 8% 
 
Only one participant (4%) felt very comfortable identifying nonulcerative 
calciphylaxis lesions prior to attending the presentation as compared to 56% following 
the presentation, an increase of 92.85%.  
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Table 5 
 
Pre/Post Self-Assessment: Comparison Between Questions 7 and 8 
Answer 
choices 
Question 7: Describe how 
comfortable you were at 
identifying ulcerative 
calciphylaxis lesions PRIOR 
to attending this presentation 
 
Question 8: Describe how 
comfortable you feel you are at 
identifying ulcerative calciphylaxis 
lesions AFTER attending this 
presentation 
 Response Percent  Response Percent 
 
Not at all. 16 64%  0 0% 
 
A little 
comfortable. 
8 32%  9 36% 
 
Very 
comfortable. 
1 4%  14 56% 
 
I am very 
knowledgeable. 
0 0%  2 8% 
 
Likewise, only one participant (4%) felt “very comfortable” identifying ulcerative 
calciphylaxis lesions prior to attending the presentation as compared with 14 participants 
(56%) who felt “very comfortable” after the presentation, an increase of 92.85%. 
One aspect of the calciphylaxis assessment is to conduct a multidimensional pain 
assessment. The PEG pain scale was selected as the multidimensional tool because it is 
easily administered at chairside and can evaluate the long-term effects of therapy. 
Table 6 examines how comfortable participants felt in conducting a 
multidimensional pain assessment using the PEG pain scale to assess calciphylaxis 
related pain. 
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Table 6 
 
Pre/Post Self-Assessment: Comparison Between Questions 9 and 10 
Answer choices 
Question 9: Describe how 
comfortable you were at 
conducting a multidimensional 
pain assessment (such as the 
PEG pain scale) BEFORE 
attending this presentation. 
 
Question 10: Describe how 
comfortable you feel you are 
conducting a 
multidimensional pain 
assessment (such as the PEG 
pain scale) AFTER 
attending this presentation. 
 Response Percent  Response Percent 
 
Not at all. 7 28%  0 0% 
 
A little 
comfortable. 
13 52%  2 8% 
 
Very 
comfortable. 
5 20%  21 84% 
 
I am very 
knowledgeable. 
0 0%  2 8% 
 
Prior to attending the presentation, all registered nurses conducted a monthly pain 
assessment using the Wong Baker FACES pain rating scale, a unidimensional pain scale. 
According to participant responses, 52% of participants felt “a little comfortable” using a 
multidimensional pain assessment. There was an increase of 76.19% in the percentage of 
participants who felt “very comfortable” conducting a multidimensional pain assessment 
following the presentation.  
Table 7 compares how comfortable participants felt in discussing the risks factors 
of calciphylaxis with their dialysis population. 
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Table 7 
 
Pre/Post Self-Assessment: Comparison Between Questions 11 and 12 
Answer 
choices 
Question 11: Describe how 
comfortable you were in 
discussing risks of 
calciphylaxis with your 
patients BEFORE to 
attending this presentation. 
 
Question 12: Describe how 
comfortable you are discussing risks 
of calciphylaxis with your patients 
AFTER attending this presentation. 
 Response Percent  Response Percent 
 
Not at all. 12 48%  0 0% 
 
A little 
comfortable. 
10 40%  4 16% 
 
Very 
comfortable. 
3 12%  19 76% 
 
I am very 
knowledgeable. 
0 0%  2 8% 
 
Prior to the presentation, 88% of participants were “not at all” comfortable or only 
“a little comfortable” in discussing risk of calciphylaxis with their patient population. 
After the presentation 76% of participants felt “very comfortable”, indicating an increase 
of 84.2% after attending the presentation. 
The final two questions were designed to determine how well the participants 
understood that calciphylaxis was not limited to cutaneous manifestations but rather was 
a progressive and systemic disease process. Table 8 shows that following the 
presentation, 92% of participants appreciated the progressive nature of the disease, an 
increase of 52.1%.  
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Table 8 
 
Pre/Post Self-Assessment: Comparison Between Questions 13 and 14 
Answer 
choices 
Question 13: BEFORE I 
attended this presentation, I 
believed that calciphylaxis 
only involved the skin. 
 
Question 14: AFTER attending this 
presentation, I believe that 
calciphylaxis only involves the skin. 
 Response Percent  Response Percent 
 
I don’t know. 5 20%  0 0% 
 
I agree with 
this statement. 
9 36%  2 8% 
 
I disagree with 
this statement 
11 44%  23 92% 
 
In conclusion, the results of the retrospective pre/post self-assessment seemed to 
support that the educational activity had been beneficial in transferring foundational 
knowledge. Additionally, the assessment indicated that the staff achieved a comfort level 
in identifying risk factors and cutaneous manifestations of calciphylaxis, and felt they 
were better prepared to discuss calciphylaxis with the dialysis patient population.  
Posttest 
The posttest was conducted online following the live presentation. The test 
comprised 21 questions and participants were required to achieve a score of 80% to pass 
the test. Participants were afforded three attempts to achieve the target score. The posttest 
covered information that was discussed during the live presentation. Sixteen participants 
completed the posttest. Eleven participants (69%) achieved a score ≥ 80% on the first 
attempt. Four other participants (24%) achieved a score ≥80% on their second attempt. 
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One participant (6%) did not achieve the target score on the first attempt and did not re-
take the test. The average test score by attempt was 81.8% on the first attempt and 85.5% 
on the second attempt. Tables 9 and 10 show the test score distribution on the first and 
last attempt. 
Table 9 
 
Test Score Distribution: First Attempt 
Test Score % Count Percent 
29% 
52% 
76% 
81% 
86% 
90% 
95% 
100% 
1 
1 
3 
3 
2 
1 
1 
4 
6% 
6% 
19% 
19% 
13% 
6% 
6% 
25% 
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Table 10 
 
Test Score Distribution: Last Attempt 
Test Score % Count 
 
Percent 
29% 
81% 
86% 
90% 
95% 
100% 
1 
5 
2 
3 
1 
4 
6% 
31% 
13% 
19% 
6% 
25% 
 
As noted above, scores improved for those four participants who opted to 
remediate and retake the posttest. There remained only one outlier as that participant 
opted out of retesting. 
Tables 11 to 31 summarize the responses to the test questions based on the last 
attempt. There were a total of 16 responses for each question. In each question, the 
correct answer is denoted by the star symbol (*). 
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Table 11 
 
Responses to Question 1 of Posttest 
Question Responses 
 
Percent 
1. The Seyle concept of calciphylaxis described a 
synthesizer/challenger interaction. Introduction 
of a synthesizer such as_____, resulted in 
increased calcium and phosphorus. After a 
latency period, exposure to a challenger, such as 
_______ produced inflammation, acute tissue 
ischemia, and tissue necrosis. 
 
a. Parathyroid hormone, metallic salts 
or albumin* 
 
b. Vitamin D, parathyroid hormone 
 
c. Iron, hyperphosphatemia 
 
d. ESRD, hyperphosphatemia 
 
 
 
 
 
 
 
 
 
 
12 
 
2 
 
0 
 
2 
 
 
 
 
 
 
 
 
 
75% 
 
13% 
 
0% 
 
13% 
 
Table 12 
 
Responses to Question 2 of Posttest 
Question Responses 
 
Percent 
 
2. Once ulceration develops, the mortality rate can increase to: 
 
a. 40% 
 
b. 60% 
 
c. 80% * 
 
d. 100% 
 
 
 
 
0 
 
1 
 
15 
 
0 
 
 
 
0% 
 
6% 
 
94% 
 
0% 
 
56 
 
Table 13 
 
Responses to Question 3 of Posttest 
Question Responses 
 
Percent 
 
3. Which is a “hallmark” sign of calciphylaxis: 
 
a. Indurated plaque 
 
b. Pain* 
 
c. Ulceration  
 
d. Bleeding 
 
e. Ischemia 
 
 
 
 
0 
 
15 
 
1 
 
0 
 
0 
 
 
 
 
0% 
 
94% 
 
6% 
 
0% 
 
0% 
 
Table 14 
 
Responses to Question 4 of Posttest 
Question Responses 
 
Percent 
 
4. The primary cause of death from calciphylaxis is from: 
 
a. Cardiac complications 
 
b. Skin necrosis 
 
c. Infection and sepsis* 
 
d. Bleeding 
 
 
 
 
0 
 
0 
 
16 
 
0 
 
 
 
 
0% 
 
0% 
 
100% 
 
0% 
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Table 15 
 
Responses to Question 5 of Posttest 
Question Responses 
 
Percent 
 
5. Calciphylaxis can be characterized as the cutaneous 
equivalent of a: 
 
a. Diabetic ulcer 
 
b. Myocardial infarction* 
 
c. Peripheral vascular disorder 
 
d. Decubitus ulcer 
 
 
 
 
 
2 
 
14 
 
0 
 
0 
 
 
 
 
 
13% 
 
88% 
 
0% 
 
0% 
 
Table 16 
 
Responses to Question 6 of Posttest 
Question Responses 
 
Percent 
6. The PEG pain scale is a three-item pain scale that assesses 
what three indicators: 
  
a. Pain intensity, eating habits, and general attitude 
 
b. Pain frequency, energy levels, and general 
awareness 
 
c. Pill burden, exhaustion, and general alertness’ 
 
d. Pain on average, enjoyment of life, and general 
activity* 
 
 
 
 
0 
 
0 
 
 
0 
 
16 
 
 
 
 
0% 
 
0% 
 
 
0% 
 
100% 
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Table 17 
 
Responses to Question 7 of Posttest 
Question Responses 
 
Percent 
 
7. The PEG pain scale is a useful tool to determine: 
 
a. Acute pain 
 
b. Chronic pain 
 
c. Response to therapy* 
 
d. Current pain levels 
 
 
 
 
0 
 
1 
 
11 
 
4 
 
 
 
 
0% 
 
6% 
 
69% 
 
25% 
 
Table 18 
 
Responses to Question 8 of Posttest 
Question Responses 
 
Percent 
 
8. A number of pharmacologic agents can be used in the 
treatment of calciphylaxis. Which one agent is a chelating 
agent for calcium: 
 
a. Cinacalcet (Senispar) 
 
b. Sodium Thiosulfate* 
 
c. Sevelamer (Renvela) 
 
d. Pamidronic Acid (Aredia) 
 
 
 
 
 
 
0 
 
13 
 
2 
 
1 
 
 
 
 
 
 
0% 
 
81% 
 
13% 
 
6% 
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Table 19 
 
Responses to Question 9 of Posttest 
Question Responses 
 
Percent 
 
9. To minimize the risk of complications, sodium thiosulfate 
should be infused over: 
 
a. 10 minutes 
 
b. 30 minutes 
 
c. 60 minutes* 
 
d. 90 minutes 
 
 
 
 
 
1 
 
2 
 
13 
 
0 
 
 
 
 
 
6% 
 
13% 
 
81% 
 
0% 
 
Table 20 
 
Responses to Question 10 of Posttest 
Question Responses 
 
Percent 
 
10. What are possible adverse effects of sodium thiosulfate? 
 
a. GI complaints 
 
b. Impaired bone integrity 
 
c. Metabolic acidosis 
 
d. None of the above 
 
e. All of the above* 
 
 
 
 
1 
 
0 
 
0 
 
0 
 
15 
 
 
 
6% 
 
0% 
 
0% 
 
0% 
 
94% 
 
60 
 
Table 21 
 
Responses to Question 11 of Posttest 
Question Responses 
 
Percentage 
 
11. Some case reports identified calciphylaxis as an 
underlying cause of: 
 
a. GI bleeding 
 
b. Temporal arteritis 
 
c. Cardiomyopathy 
 
d. All of the above* 
 
e. None of the above 
 
 
 
 
0 
 
2 
 
2 
 
11 
 
1 
 
 
 
 
0% 
 
13% 
 
13% 
 
69% 
 
6% 
 
Table 22 
 
Responses to Question 12 of Posttest 
Question Responses 
 
Percent 
 
12. Acral ischemia is a(n) _____ presentation involving the 
____: 
 
a. Typical, genitals and digits 
 
b. Typical, buttocks and thighs 
 
c. Atypical, buttocks and thighs 
 
d. Atypical, genitals and digits* 
 
 
 
 
 
2 
 
1 
 
0 
 
13 
 
 
 
 
 
13% 
 
6% 
 
0% 
 
81% 
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Table 23 
 
Responses to Question 13 of Posttest 
Question Responses 
 
Percent 
 
13. This image is an example of what type of calciphylaxis 
lesion? (the embedded link took the participant to an image 
for identification of the lesion) 
 
a. Acral* 
 
b. Distal 
 
c. Proximal 
 
d. Medial 
 
 
 
 
 
 
15 
 
1 
 
0 
 
0 
 
 
 
 
 
 
94% 
 
6% 
 
0% 
 
0% 
 
Table 24 
 
Responses to Question 14 of Posttest 
Question Responses 
 
Percent 
 
14. Name the stage of lesion – select the letter that corresponds 
to the image. (the embedded link took the participant to an 
image for identification of the lesion) 
 
a. Early stage 
 
b. Mid stage 
 
c. Late stage* 
 
 
 
 
 
0 
 
1 
 
15 
 
 
 
 
 
 
0% 
 
6% 
 
94% 
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Table 25 
 
Responses to Question 15 of Posttest 
Question Responses 
 
Percent 
 
15. Name the stage of lesion – select the letter that corresponds 
to the image. (the embedded link took the participant to an 
image for identification of the lesion) 
 
a. Early stage 
 
b. Mid stage* 
 
c. Late stage 
 
 
 
 
 
2 
 
13 
 
1 
 
 
 
 
 
 
13% 
 
81% 
 
6% 
 
Table 26 
 
Responses to Question 16 of Posttest 
Question Responses 
 
Percent 
 
16. Name the stage of lesion – select the letter that corresponds 
to the image. (the embedded link took the participant to an 
image for identification of the lesion) 
 
a. Early stage* 
 
b. Mid stage 
 
c. Late stage 
 
 
 
 
 
15 
 
1 
 
0 
 
 
 
 
 
 
94% 
 
6% 
 
0% 
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Table 27 
 
Responses to Question 17 of Posttest 
Question Responses 
 
Percent 
 
17. Identify the calciphylaxis lesion. Select the letter that 
corresponds to the image. (the embedded link took the 
participant to an image for identification of the lesion) 
 
a. Livedo racemose – like purpura 
 
b. Indurated plaque 
 
c. Hemorrhagic patches* 
 
d. Subcutaneous nodules 
 
e. Necrotic ulceration 
 
 
 
 
 
 
1 
 
0 
 
11 
 
0 
 
4 
 
 
 
 
 
6% 
 
0% 
 
69% 
 
0% 
 
25% 
 
Table 28 
 
Responses to Question 18 of Posttest 
Question Responses 
 
Percent 
 
18. Identify the calciphylaxis lesion. Select the letter that 
corresponds to the image. (the embedded link took the 
participant to an image for identification of the lesion) 
 
a. Livedo racemose – like purpura 
 
b. Indurated plaque* 
 
c. Hemorrhagic patches 
 
d. Subcutaneous nodules 
 
e. Necrotic ulceration 
 
 
 
 
 
 
0 
 
13 
 
2 
 
1 
 
0 
 
 
 
 
 
0% 
 
81% 
 
13% 
 
6% 
 
0% 
 
64 
 
Table 29 
 
Responses to Question 19 of Posttest 
Question Responses 
 
Percent 
 
19. Identify the calciphylaxis lesion. Select the letter that 
corresponds to the image. (the embedded link took the 
participant to an image for identification of the lesion) 
 
a. Livedo racemose – like purpura* 
 
b. Indurated plaque 
 
c. Hemorrhagic patches 
 
d. Subcutaneous nodules 
 
e. Necrotic ulceration 
 
 
 
 
 
 
15 
 
0 
 
0 
 
1 
 
0 
 
 
 
 
 
94% 
 
0% 
 
0% 
 
6% 
 
0% 
 
Table 30 
 
Responses to Question 20 of Posttest 
Question Responses 
 
Percent 
 
20. Identify the calciphylaxis lesion. Select the letter that corresponds to the 
image. (the embedded link took the participant to an image for 
identification of the lesion) 
 
a. Livedo racemose – like purpura 
 
b. Indurated plaque 
 
c. Hemorrhagic patches 
 
d. Subcutaneous nodules 
 
e. Necrotic ulceration*  
 
 
 
 
 
1 
 
0 
 
1 
 
0 
 
14 
 
 
 
 
 
6% 
 
0% 
 
6% 
 
0% 
 
88% 
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Table 31 
 
Responses to Question 21 of Posttest 
Question Responses 
 
Percent 
 
21. Identify the calciphylaxis lesion. Select the letter that corresponds to the 
image. (the embedded link took the participant to an image for 
identification of the lesion) 
 
a. Livedo racemose – like purpura 
 
b. Indurated plaque 
 
c. Hemorrhagic patches 
 
d. Subcutaneous nodules* 
 
f. Necrotic ulceration 
 
 
 
 
 
0 
 
1 
 
0 
 
13 
 
2 
 
 
 
 
0% 
 
6% 
 
0% 
 
81% 
 
13% 
 
Areas of weakness on the test were mainly with identification of the different 
wound types. In reality, it is not important that the staff can identify the stage or severity 
of the wound type. Diagnosis of calciphylaxis is generally based on clinical presentation. 
Emphasis is placed on the identification of a wound in the clinical setting, rather than the 
stage or type of wound. The exemplars of wounds discussed during the live event and 
presented on the posttest are indications a few of the different ways in which 
calciphylaxis wounds can manifest in actual practice. 
Activity Specific/Outcome Measure Evaluation 
The activity specific/outcome measure evaluation comprised two questions.  
Question 1. The first question utilized a 5-point Likert scale and asked 
participants to rate their responses on a scale of 1 (strongly disagree) to 5 (strongly 
agree) to the following question: “After attending this educational offering, I have a 
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better knowledge base to assess, identify, and implement practices, which may improve 
outcomes for patients with calciphylaxis”. Fourteen participants completed this survey. 
There were 13 who responded with a 5 (strongly agree) and one with a response of 3 
(neutral). The mean of all respondents was 4.857. The overall response rate would 
indicate that the teaching strategies used for the educational activity were effective in 
teaching the staff to incorporate this knowledge in clinical practice.  
Question 2. Thirteen participants responded to the second question, which asked 
them to name one thing learned that could be implemented into current practice. As Table 
32 shows, participants retained concepts that were emphasized in the educational activity 
such as (a) high mortality rates, (b) early recognition and treatment, (c) the importance of 
the pain assessment, (d) patient education, and (e) the importance of calciphylaxis 
screening. 
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Table 32 
 
One Thing I Learned by Attending This Presentation Is: 
Participant Answer 
 
 
Response 1 
 
Response 2 
 
Response 3 
 
Response 4 
 
Response 5 
 
Response 6 
 
Response 7 
 
 
Response 8 
 
Response 9 
 
 
Response 10 
 
 
 
 
 
Response 11 
 
 
Response 12 
 
 
Response 13 
 
 
 
Treatment of calciphylaxis. 
 
Identification and classification of different lesions. 
 
As a SW, I now have a greater understanding of calciphylaxis. 
 
Importance of a good physical exam. 
 
You can never ask enough questions about pain. 
 
Better assessment skills to screen for calciphylaxis. 
 
My increased knowledge on the subject will help me educate my 
patients. 
 
Calciphylaxis death. 
 
Being more aware of calciphylaxis and screening more for it. It is 
critical to catch it early and important to advocate for the patients. 
 
I have learned some of the benefits of the PEG Pain Scale and 
will be able to implement this scale into my practice.  
This multidimensional scale with help me understand my 
patient’s response to treatment by assessing what my patients 
pain on average, enjoyment of life, and general activity is. 
 
How to better assess for calciphylaxis and how to determine what 
stage a lesion is. 
 
Signs and symptoms of calciphylaxis and importance of early 
diagnosis. 
 
Using a more holistic pain scale. 
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Shared Enduring Activity Evaluation 
The shared enduring activity evaluation is an assessment to determine if the 
participant was able to achieve the program objectives and assure that the activity was 
free from commercial bias. Twelve participants completed the shared enduring activity 
evaluation. The evaluation contained nine questions. 
Question 1. “The content of this presentation was free from bias, commercial 
influence and product promotion”. Twelve respondents (100%) answered true. 
Question 2. “Please note below if you noted bias, commercial influence or 
product promotion within this presentation”. Four respondents’ answers indicated no 
bias. Eight respondents made no comment. 
Question 3. “I attest that I attended this activity”. Twelve respondents (100%) 
attested affirmatively. 
Question 4. Question 4 contained two queries and the respondents were asked to 
rate each according to the following scale: 1 = strongly disagree, 2 = disagree, 3 = 
neutral, 4 = agree, 5 = strongly agree. Table 33 illustrates that all 12 respondents felt that 
this presenter demonstrated knowledge and expertise in the content area. The second 
query regarded content relevance to practice. In response to this question, one respondent 
(8%) rated the relevance as 3 (neutral). The other 11 respondents (92%) answered with a 
rating of 5 . 
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Table 33 
 
Question 4: Please Rate the Following 
Question Scale Count Percent 
The presenter demonstrated knowledge 
and expertise in the content area 
1 = Strongly Disagree 
2 
3 
4 
5 = Strongly Agree 
 
0 
0 
0 
0 
12 
0% 
0% 
0% 
0% 
100% 
    
The subject matter was relevant to my 
current practice 
1 = Strongly Disagree 
2 
3 
4 
5 = Strongly Agree 
 
0 
0 
1 
0 
11 
0% 
0% 
8% 
0% 
92% 
    
(1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree) 
 
Question 5. The material in this presentation enhanced my knowledge, skills, 
and/or practice. Table 34, outlines the responses and showed that 67% of participants 
noted that they had gained knowledge as a result of the presentation. 
Table 34 
 
Question 5. The Material in This Presentation Enhanced my Knowledge, Skills, and/or 
Practice 
Response Count Percent 
Knowledge – I have learned 8 67% 
Skills – I can perform 1 8% 
Practice – I can implement or change 3 25% 
 
Question 6. Commitment to change practice. The purpose of the commitment to 
change practice evaluation is multifactorial and can be a powerful measure of evaluating 
70 
 
how effectively the learning activity impacted the application of newly acquired 
knowledge and implementation of this knowledge into clinical practice (Shershneva, 
Wang, Lindeman, Savoy, & Olson, 2010). Table 35 demonstrates that 67% of 
respondents intended to make a change to their current practice as a result of this 
educational activity. One respondent (8%) anticipated some barriers that might hinder a 
change in practice. 
Table 35 
 
Question 6: Commitment to Change Practice 
Response Count Percent 
I will make a change to my current practice as a result of 
the educational session 
8 67% 
I am considering a change in my current practice as a result 
of the educational session 
2 17% 
This educational session confirms my current practice 1 8% 
I am not yet convinced that any change in practice is 
warranted  
0 0% 
I perceive that there may be barriers to changing my 
practice (further detail can be provided in Q8) 
1 8% 
 
Question 7. What information from this session do you plan to implements in 
practice? This query solicited a free text entry. Six participants answered this question. 
Table 36 outlines the responses.  
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Table 36 
 
Question 7: What Information From This Session Do You Plan to Implement Into 
Practice? 
Participant Answer 
Response 1 How to treat calciphylaxis 
Response 2 Monthly assessment 
Response 3 Using screening tool 
Response 4 Using the screening tool as a way to advocate to 
MDs for my patients 
Response 5 PEG Pain Scale 
Response 6 The PEG pain tool 
 
Question 8. What are the perceived barriers to implementing information from 
this session into practice? This query solicited a free text response. Eight respondents 
commented and Table 37 outlines their responses. The responses indicated that the most 
perceived barrier is acceptance and incorporation into practice by the organization as the 
assessment tool is not validated. These are legitimate concerns that need to be addressed 
in future endeavors. 
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Table 37 
 
Question 8: What Are Perceived Barriers to Implementing Information From This 
Session Into Practice? 
Participant Answer 
Response 1 None 
Response 2 None 
Response 3 As a SW [social worker], I will direct concerns to 
RNs, NPs, and MDs 
Response 4 Company policy and procedure 
Response 5 Not approved for use 
Response 6 I think others are too cautious to consider 
calciphylaxis as a diagnosis. I believe others just 
don’t know enough about it. I am grateful for the 
education. 
Response 7 N/A 
Response 8 Patient’s participating and being truthful on 
assessment 
 
Additional comments regarding barriers were discussed during the live 
presentation. One nurse commented that she was afraid of over-reaching and acting 
outside the scope of nursing practice because she felt she was making a medical 
diagnosis. While this is a valid concern, I stressed that she was not making a diagnosis, 
but rather was conducting an assessment and reporting findings to a provider for further 
evaluation.  
Question 9. Provide any additional feedback that you may have about the 
material, the author/presenter of ideas for other educational offerings that would be of 
interest to you. Five participants commented and their responses are outlined in table 38. 
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Table 38 
 
Question 9: Provide Any Additional Feedback That You May Have About the Material, 
the Author/Presenter of Ideas for Other Educational Offerings That Would Be of Interest 
to You 
Participant Answer 
Response 1 Great presentation and presenter very 
knowledgeable in subject 
Response 2 Very informative 
Response 3 It was extremely helpful and will be information I 
use for years to come. Thanks 
Response 4 N/A 
Response 5 I thought that this presentation was very 
informational helped me to better understand 
calciphylaxis and how to assess for it. The images 
were also helpful in order to help determine what 
stage the lesions were 
 
Evaluation of the Calciphylaxis Risk Assessment and Screening Tool 
The final evaluation focused on the calciphylaxis screening tool. This was a 10-
question evaluation aimed at appraising the screening instrument for functionality and 
workability for use in the clinical setting. A total of 25 participants completed the 
evaluation. As tables 39 to 48 show, the assessment form overall was well received with 
some suggestions for improvement.  
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Table 39 
 
Calciphylaxis Screening Tool: Question 1 
Answer choices Responses Percent 
   
Amount of Information 
 
A. Just right 
 
B. Too little 
 
C. Too much 
 
 
25 
 
0 
 
0 
 
 
100% 
 
0% 
 
0% 
   
Comments 
 
Very Useful 
  
 
Table 40 
 
Calciphylaxis Screening Tool: Question 2 
Answer choices Responses Percent 
   
The color scheme is 
 
A. Engaging 
 
B. Neutral 
 
C. Disruptive 
 
 
17 
 
8 
 
0 
 
 
68% 
 
32% 
 
0% 
   
Comments 
 
Add color/photos for lesions possibly 
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Table 41 
 
Calciphylaxis Screening Tool: Question 3 
Answer choices Responses Percent 
   
Clarity of instructions 
 
A. Very clear 
 
B. Somewhat clear 
 
C. Not clear at all 
 
 
25 
 
0 
 
0 
 
 
100% 
 
0% 
 
0% 
   
Comments 
 
There were no additional comments 
  
 
Table 42 
 
Calciphylaxis Screening Tool: Question 4 
Answer choices Responses Percent 
   
Ease of use 
 
A. Very clear 
 
B. Somewhat clear 
 
C. Not clear at all 
 
 
25 
 
0 
 
0 
 
 
100% 
 
0% 
 
0% 
   
Comments 
 
There were no additional comments 
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Table 43 
 
Calciphylaxis Screening Tool: Question 5 
Answer choices Responses Percent 
   
Amount of information to guide a systematic review 
 
A. Sufficient 
 
B. Helpful 
 
C. Insufficient 
 
 
21 
 
4 
 
0 
 
 
84% 
 
16% 
 
0% 
   
Comments 
 
There were no additional comments 
  
 
Table 44 
 
Calciphylaxis Screening Tool: Question 6 
Answer choices Responses Percent 
   
Relevance to practice 
 
A. Very relevant 
 
B. Somewhat relevant 
 
C. Not relevant at all 
 
 
24 
 
0 
 
1 
 
 
96% 
 
0% 
 
1% 
   
Comments 
 
Social worker 
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As noted, one participant felt that as a social worker, the assessment form was not 
relevant to her practice. This concern is valid; as such an assessment would only be 
within the scope of practice for registered nurses. 
Table 45 
 
Calciphylaxis Screening Tool: Question 7 
Answer choices Responses Percent 
   
Would you recommend this form to a colleague? 
 
A. Would recommend 
 
B. Might recommend 
 
C. Would not recommend 
 
 
24 
 
1 
 
0 
 
 
96% 
 
4% 
 
0% 
   
Comments 
 
There were no additional comments 
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Table 46 
 
Calciphylaxis Screening Tool: Question 8 
Answer choices Responses Percent 
   
Would you anticipate any barriers that might impede 
incorporating this tool in your practice? 
 
D. No barriers 
 
E. Maybe 
 
F. Definite barriers 
 
 
 
19 
 
6 
 
0 
 
 
 
76% 
 
24% 
 
0% 
   
Comments 
 
1. RN staffing on the ICHD [incenter hemodialysis] floor. 
Easy use in home dialysis setting 
 
2. Nonverbal 
 
3. Some MDs might not want us assessing/stepping over 
boundaries 
 
4. Engagement of staff 
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Table 47 
 
Calciphylaxis Screening Tool: Question 9 
Answer choices Responses Percent 
   
Amount of use 
 
A. Would use all the time 
 
B. Would use sometimes 
 
C. Would not use 
 
 
23 
 
1 
 
1 
 
 
92% 
 
4% 
 
4% 
   
Comments 
 
Social Worker 
  
 
As previously noted, the assessment form is not appropriate for all 
interdisciplinary team members and, therefore, would not be a functional tool in all 
situations. 
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Table 48 
 
Calciphylaxis Screening Tool: Question 10 
Answer choices Responses Percent 
   
Overall, how would you rate the assessment form? (This 
was a 4-star rating system) 
 
☆  - Poor 
 
☆☆ - Fair 
 
☆☆☆ - Good 
 
☆☆☆☆  - Excellent 
 
 
Weighted average = 3.96 
 
 
 
0 
 
0 
 
1 
 
24 
 
 
 
0% 
 
0% 
 
4% 
 
96% 
   
 
 
Comments 
 
1. Very good! 
 
2. This was very informative, and this would be a 
great tool to implement. 
 
3. You are a genius. 
 
4. Thank you, really enjoyed the presentation. 
Learned a lot and one of the best presentations I 
have had yet. 
 
5. Instead of hyperphos, hypercal, hypoalb, use 
phos >/= ______, Ca >/= ______, alb </= 
______; change Coumadin (brand name) to 
warfarin. 
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Recommendations 
When reviewing the subjective and objective results of all the evaluations, the 
educational component of this DNP project would indicate that staff did acquire the 
knowledge necessary to conduct a calciphylaxis screening and the skills to identify 
calciphylaxis lesions in the clinical setting. The screening tool was well received by the 
staff and many of the participants asked for a copy of the tool so they could begin 
performing assessments on their own. As I stressed to the staff, this tool has not yet been 
validated and is not approved for use at the dialysis facility. Until the tool is validated, I 
recommended that the tool could be used as an interdisciplinary approach to collaborate 
with the ESRD patient and develop a patient-centered plan of care aimed at reducing 
disease burden, enhancing quality of life and, ultimately, improving population health. 
Strengths and Limitations of the Project 
Strengths 
This project is the first to evaluate effects of staff education related to the 
identification of early calciphylaxis. The screening tool is the first to be developed for use 
in clinical practice.  
Limitations  
This project took place in a single center with a limited and small participant 
sample size. Although continuing education credits (1.5 hours) were offered, there were a 
very small number of participants who actually claimed these credits. This low number of 
continuing education credits may have impacted the sample size negatively for some of 
the evaluations. Clearly, the sample sizes were larger for the paper-based evaluations 
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conducted immediately after the live event. One remedy to improve the sample size 
would have been to add a web-based offering through the Walden University School of 
Nursing Continuing Nurse Education Library and opening it to a larger participant pool.  
Evaluations conducted at the end of the live activity only evaluated immediate 
and short-term knowledge retention. Because routine calciphylaxis screening cannot be 
immediately implemented, there is no evidence to evaluate long-term knowledge 
retention. There will need to be further studies to determine knowledge retention in the 
long-term and to determine whether staff are actually able to identify calciphylaxis 
lesions in routine screening. These questions need to be answered outside of my original 
DNP project. In the meantime, dissemination of my calciphylaxis education can be 
provided to other dialysis clinics locally. 
Implementing the screening tool can be an important step to improve population 
health. Unfortunately, it has not been validated and, therefore, is not ready to be placed 
into practice. The screening tool was well received by the participants as evidenced by 
the evaluations. I do have plans to have the tool validated and then disseminate it to other 
nephrology providers. I also plan to work with my partner dialysis organization to 
integrate calciphylaxis into clinical practice. 
Calciphylaxis detection is a secondary prevention nursing action that has potential 
for promoting social change by improving patient outcomes, reducing mortality rates in 
the end stage renal disease population, and providing empiric data to inform evidence-
based therapies for all patients at risk of developing calciphylaxis. 
83 
 
Section 5: Dissemination Plan 
The American Nephrology Nurses Association (ANNA) is an organization that 
can provide several avenues for dissemination. ANNA was established in 1969 and 
currently has a membership that exceeds 9,000 nephrology professionals (ANNA, 
2018a). The Nephrology Nursing Journal is the official journal of ANNA. This journal is 
peer reviewed and publishes current research, educational articles, and manuscripts on 
current issues of interest to the nephrology community (ANNA, 2018b). ANNA also 
hosts two national seminars yearly. I submitted an abstract (Appendix D) and my 
application was accepted (Appendix E) to present a poster at the ANNA 2018 National 
Symposium. By disseminating my assessment tool, I hope to raise awareness for the need 
to conduct routine calciphylaxis screening. Once validated, I plan to introduce the tool to 
my partner organization for the purpose of conducting a pilot study and implementing a 
calciphylaxis screening program. 
As demonstrated, education on calciphylaxis is paramount in any effort to initiate 
a successful screening protocol. I plan to develop a continuing education manuscript and 
submit this to the Nephrology Nursing Journal for consideration. Lastly, I can prepare a 
continuing education webinar add to the Walden University School of Nursing 
Continuing Education Library so this education can be shared on a global scale. 
Analysis of Self 
As I have embarked on my educational journey from the early beginnings of a 
registered nurse, to a master level nurse practitioner, and now a doctoral student, I have 
come to appreciate how lifelong learning contributes to self-efficacy and competence. I 
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also appreciate the value of sharing knowledge with other medical professionals and most 
importantly, the populations that we serve. Evidence-based medicine is now the standard 
of care, and as I move forward in my career, I will seek out the best evidence to support 
of my delivery of care. As I worked on this DNP project, I found that there has been a 
lack of evidence to guide the treatment of calciphylaxis, but the nephrology community is 
now beginning to produce research in the field that can finally provide the evidence that 
is needed to improve clinical outcomes in the nephrology population. Two such studies 
are the CALISTA study (ClinicalTrials.gov, 2017) and the VITK-CUA study 
(ClinicalTrials.gov, 2014). 
The CALISTA study is a Phase 3 clinical trial studying the use of intravenous 
sodium thiosulfate in acute calciphylaxis. This research is being conducted as a 
multicenter, randomized, double-blind, placebo-controlled study (ClinicalTrials.gov, 
2017). The evaluation of vitamin K supplementation for calcific uremic arteriolopathy 
(VITK-CUA) study is a pilot study examining the use of vitamin K in patients at risk to 
develop calciphylaxis (ClinicalTrials.gov, 2014). It was very exciting to find reference to 
these two studies and I will be following them closely.  
As I developed my DNP project, I was able to network with several prominent 
nephrologists who are actively studying calciphylaxis. As I progress in my role as a DNP, 
I will maintain these professional relationships because I realize that research is dynamic 
and calciphylaxis management is an area that is now ripe for research. 
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Summary 
This DNP journey has been one of professional fulfillment. I was able to identify 
a longstanding need for calciphylaxis screening and take an active role in improving 
patient outcomes. I expanded my professional network by aligning myself with experts in 
the field of calciphylaxis research. In this way, I discovered a whole new area of 
nephrology research. I was privileged to mentor dialysis staff at point of care and 
hopefully played a role in transforming care at the chairside through education.  
Once fully developed and validated, the calciphylaxis assessment and screening 
tool can be used as an interdisciplinary approach to achieve early intervention by 
empowering nephrology nurses to assume a proactive leadership role in calciphylaxis 
disease management. Together, the nurse leader and interdisciplinary team members, 
collaborating with the ESRD patient, could develop a patient-centered plan of care aimed 
at reducing disease burden, enhancing quality of life and improving population health. 
The assessment and screening tool has the potential to address a longstanding practice 
void in the continuing care of the ESRD population. While developing the calciphylaxis 
screening and assessment tool is one stepping stone in calciphylaxis management, it does 
not stand alone. Staff and patient education remain integral to improving quality of life in 
the ESRD patient population, reducing symptom burden, and decreasing mortality rates. 
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